Pirtobrutinib
Brand name: Jaypirca
Pirtobrutinib comes in 4 pill versions in our database, in 2 strengths, from 2 manufacturers. Check the imprint to tell them apart.
Pirtobrutinib pill images
50 mg 2 pills
- Lilly50 6902 Pirtobrutinib 50 mg Blue, triangle, 9 mm Used for mantle-cell lymphoma
- Lilly 50 6902 Pirtobrutinib 50 mg Blue, triangle Used for mantle-cell lymphoma
100 mg 2 pills
What is Pirtobrutinib used for?
Pirtobrutinib is used for mantle-cell lymphoma.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Mantle Cell Lymphoma
JAYPIRCA® is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy, including a BTK inhibitor.
This indication is approved under accelerated approval based on response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
JAYPIRCA is indicated for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) who have previously been treated with a covalent BTK inhibitor.
From the FDA-approved label on DailyMed (published Mar 25, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.